Company intelligence / Profile preview

Irvine Pharmaceutical Services

San Juan Capistrano, California, United Statesirvinepharma.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Irvine Pharmaceutical Services provided cGMP product development, analytical development, parenteral manufacturing, stability storage, and CMC testing for pharmaceutical and biopharmaceutical clients. The company was acquired by Nitto Denko Avecia Inc. in October 2016 to expand analytical capabilities and complement oligonucleotide drug substance services.

Modalities: Small moleculeBiologicParenteral drug productsDrug delivery device testing
Industry: Contract Manufacturing Organization

Partnerships

Clients include pharmaceutical, biopharmaceutical, and medical device companies globally.

Beyond the preview

Go deeper on Irvine Pharmaceutical Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Irvine Pharmaceutical Services.

Explore the full profile